TOX as a potential target for immunotherapy in lymphocytic malignancies

Abstract

Abstract TOX (thymocyte selection-associated HMG BOX) is a member of a family of transcriptional factors that contain the highly conserved high mobility group box (HMG-box) region. Increasing studies have shown that TOX is involved in maintaining tumors and promoting T cell exhaustion. In this review, we summarized the biological functions of TOX and its contribution as related to lymphocytic malignancies. We also discussed the potential role of TOX as an immune biomarker and target in immunotherapy for hematological malignancies.

Keywords

• Thymocyte selection-associated HMG BOX
• Biological function
• T cell exhaustion
• Lymphocytic malignancies
• Immune biomarker
• Immunotherapy